|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/02 | |
| A61K 47/12 | |||
| A61K 47/14 | |||
| A61P 35/00 | |||
| A61P 19/02 | |||
| A61K 31/519 | |||
| A61K 9/00 | |||
| A61K 9/08 |
| (11) | Number of the document | 2614814 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12160858.2 |
| Date of filing the European patent application | 2012-03-22 | |
| (97) | Date of publication of the European application | 2013-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201200192 | 2012-01-16 | GB |
| (72) |
Tierney, Carl, GB
Powell, Stacey, GB
Braybrooke, Peter, GB
Jones, Geraint, GB
|
| (73) |
Rosemont Pharmaceuticals Ltd,
Rosemont House Yorkdale Industrial Park Braithwaite Street, Leeds LS11 9XE,
GB
|
| (54) | Methotrexate composition |
| Methotrexate composition |